Mike Young

Mike Young is Co-Founder and President of Comanche Biopharma where he is responsible for translating company strategy into operations and achieving our vision of making every pregnancy around the world safer. Previous to Comanche, Mike was Vice President of Commercial Planning and Healthcare Provider Strategy at The Medicines Company (MDCO) where he was responsible for the global pre-commercialization, go to market planning, lifecycle, and competitive intelligence strategy for Leqvio (Inclisiran) through to its acquisition by Novartis in 2020. Mike held various positions of leadership in his more than 11 years at MDCO, including Chief Learning Officer and Head of Marketing for the post-operative business unit. Mike has played an operating leadership role in the development, approval and launch of a dozen novel therapeutics in the areas of acute cardiovascular, surgery, infectious disease, and anesthetics. Previously, Mike worked for Massachusetts General Hospital (MGH) and the Center for Integration of Medicine and Innovative Technology (CIMIT). Mike grew up in northern New Mexico.